Analyst Target Adjustments Hit Accenture (ACN), Thomson Reuters (TRI) and TELUS (TU)

Three names across IT services, financial media and Canadian telecom are drawing fresh analyst attention this week. Truist lowered its price target on Accenture ( NYSE:ACN) to $260 from $317, keeping a Buy rating, citing stagnant enterprise AI demand and potential risk to fiscal 2027 consensus estimates.

Meanwhile, Bank of America raised its target on Thomson Reuters ( NASDAQ:TRI) to $115 from $100 ahead of a management fireside chat, and upgraded TELUS ( NYSE:TU) to Buy from Neutral with a new $16 target, pointing to an aggressive deleveraging path and roughly $7 billion in monetization opportunities following a CEO transition.

Ticker Company Firm Old Rating New Rating Old Target New Target Current Price One-Line Takeaway ACN Accenture Truist Buy Buy $317 $260 $209.36 Target cut reflects near-term AI demand uncertainty; Buy maintained TRI Thomson Reuters BofA Neutral Neutral $100 $115 $111.52 Target raised on durable growth and margin confidence ahead of management event TU TELUS BofA Neutral Buy $14.50 $16 $13.67 Upgraded on CEO change catalyst and $7B monetization pipeline The Analysts’ Cases Accenture: Truist Stays Bullish but Trims Expectations

Truist kept its Buy rating on Accenture but lowered the price target to $260 from $317, reflecting what the firm describes as stagnant enterprise AI adoption and a growing risk that fiscal year 2027 consensus estimates are too high. The concern centers on slower ecosystem spending and the possibility that AI tools are beginning to cannibalize traditional consulting billable hours rather than supplement them. This is a structural debate playing out across the IT services sector: Morningstar recently flagged similar concerns, noting that AI presents headwinds through reduced billable hours even as it drives client infrastructure upgrade demand. Truist appears to be pricing in more of the former, at least in the near term.

Thomson Reuters: BofA Lifts Target on Growth Conviction

Bank of America raised its Thomson Reuters target to $115 from $100 while keeping a Neutral rating, citing greater confidence in durable high-single-digit revenue growth, margin expansion, capital returns, and the potential for accretive acquisitions. The timing coincides with an upcoming management fireside chat, suggesting BofA sees the event as a potential catalyst for broader investor recognition of the company’s trajectory. Thomson Reuters delivered 9% organic revenue growth across its Big 3 segments in Q4 2025, and management guided for 7.5% to 8.0% organic revenue growth for full year 2026.

TELUS: BofA Upgrades on Deleveraging and Monetization Path

Bank of America upgraded TELUS to Buy from Neutral and raised the target to $16 from $14.50, pointing to an accelerated approach to leverage reduction following the CEO transition and identifying $7 billion in monetization opportunities. Outgoing CEO Darren Entwistle, who retires June 30, 2026, is being succeeded by former CIBC chief Victor Dodig, effective July 1, 2026. TELUS has already taken steps to strengthen its balance sheet, including a tower partnership with La Caisse that reduced net debt by $1.26 billion. The company is also exploring strategic partnership options for TELUS Health, with 75 potential parties reported to have expressed interest in a minority stake, spin-off, or strategic investment.

Company Snapshot and Recent Performance

Accenture has had a difficult 2026 so far. The stock is down 21.51% year to date and has fallen 37.4% over the past year, now trading near its 52-week low of $188.73. The stock currently trades at roughly 17x trailing earnings, well below its 200-day moving average of $262.40. Despite the pressure, the company posted Q4 FY2025 revenue of $17.60 billion and new bookings of $21.3 billion, with CEO Julie Sweet citing 7% growth in fiscal 2025 and AI reinvention demand as key drivers.

Thomson Reuters has been volatile. After falling 14.78% year to date through early March, the stock surged 12.09% in the past week and is now trading at $111.52, just below BofA’s new $115 target. The company’s full-year 2025 free cash flow came in at $1.950 billion, up 10.72% year over year, and it recently announced its 33rd consecutive annual dividend increase.

TELUS has held relatively steady, up 3.8% year to date at $13.67. The stock carries a dividend yield of approximately 12.1%, with a quarterly dividend of CAD $0.4184 per share with a record date of March 11, 2026.

Why the Moves Matter Now

For Accenture, the Truist target cut to $260 remains above the current price of $209.36, but the direction of the revision matters. The consensus analyst target sits at $285.48, and Deutsche Bank separately cut its target to $230 from $280 last week. The pattern of downward revisions suggests the market is recalibrating expectations for how quickly AI consulting demand will materialize into revenue. FY2026 guidance of GAAP diluted EPS of $13.19 to $13.57 gives investors some earnings floor, but the concern is what comes after.

For Thomson Reuters, BofA’s target of $115 is essentially in line with where the stock already trades, making this more of a confidence signal than a valuation call. The real story is the 2026 guidance: management projects Big 3 segment total revenue growth of approximately 9.5% and free cash flow of approximately $2.1 billion. CEO Steve Hasker has pointed to agentic AI capabilities as the next growth layer, noting the company is focused on “scaling our agentic capabilities to deliver greater speed, clarity, and confidence for our customers.”

For TELUS, the upgrade carries the clearest near-term catalyst: a new CEO, an active monetization process for TELUS Health, and a deleveraging path that targets net debt-to-adjusted EBITDA of 3.0x by year-end 2027, down from 3.4x currently. The AI revenue trajectory, from approximately $800 million in 2025 toward a target of approximately $2 billion by 2028, adds a growth angle that extends beyond traditional telecom metrics.

What Analysts Are Watching

Accenture carries a 2.89% dividend yield and broad analyst support, though Truist has flagged near-term earnings revision risk. Thomson Reuters offers low-volatility characteristics with a beta of 0.167 and consistent cash generation, though the stock has limited upside to BofA’s new target from current levels. TELUS offers the highest income component of the three but comes with a payout ratio that analysts have flagged as elevated relative to current earnings.

Key Risks to Watch

• Accenture AI cannibalization: If AI tools reduce the volume of billable consulting hours faster than new AI-related project work comes in, consensus estimates for FY2027 could face meaningful downward pressure, as Truist’s note suggests.
• TELUS dividend sustainability: The stock’s 12.1% dividend yield is a draw for income investors, but the payout ratio relative to current earnings warrants scrutiny. Any reduction in the dividend would likely pressure the share price significantly.
• Thomson Reuters valuation and macro: With the stock now trading near BofA’s raised target of $115, much of the near-term good news may already be reflected. A deteriorating macroeconomic environment or slower-than-expected AI product adoption could limit further upside from current levels.

This is not personalized financial advice. 247wallst.com and its writers do not own the stocks mentioned. Always do your own due diligence before investing.